A tip for the inquisitive journalist
The take away from #FDA's approval of #Hemgenix - a #genetherapy for #hæmophiliaB - has been that Hemgenix is now the most expensive drug in the world, because manufacturer #CSLBehring priced the treatment at 3.5 million $ after it was approved
via #theguardian
https://bit.ly/3tVt0NJ
But what about focusing on how that price tag was calculated?
Andf if #CSLBehring are following a trend seen with other new drugs for chronic conditions 1/

In doing so, #CSLBehring follows a trend seen with other new drugs for chronic conditions, whose asking price does not so much reflect the actual costs of development and manufacturing plus a profit, but rather what they expect governments and insurance companies to be willing to pay

The good news is, the FDA has approved #Hemgenix, an apparently effective treatment for #hemophiliaB - which is characterized by a lack of the clotting factor IX
The not-so-good news is that manufacturer #CSLBehring, after approval, has priced the treatment - a #genetherapy - at $3.5 million a dose, making it the most expensive drug in the world
via @guardian
https://bit.ly/3tVt0NJ